{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:32:50Z","timestamp":1787758370440,"version":"build-2784847793"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Myopia is the most common type of refractive error and the leading cause of functional visual loss. Increased risk of myopic maculopathy, retinal detachment, glaucoma and cataract has been seen with a myopia of as low as \u22121D. This study was done to determine the effect of atropine 0.01% eye drops on the progression of myopia in children &gt;5 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This was a single-blind, prospective, randomized case\u2013control study which included children of 5\u201315 years with myopia of &gt;2D and were divided into treatment group (group 1) and placebo group (group 2). Children under treatment group were treated with application of 0.01% atropine at night. Children with history of any ocular surgery, chronic ophthalmic illness, squint and amblyopia were excluded from the study. The follow-up for myopia progression was done for two years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      This study showed a significant difference in increase of spherical equivalent and axial length among treatment and placebo groups after a duration of two years. Total duration of follow up was twenty-four months. Mean increase in axial length of group 1 and 2 was 0.115 mm and 0.32 mm, respectively. Mean increase in refraction of groups 1 and 2 was \u22120.30 D and \u22120.88 D, respectively, showing significant change in axial length and refraction (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study supports the use of atropine 0.01% eye drops in reducing the progression of myopia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_256_22","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T05:38:02Z","timestamp":1661751482000},"page":"3373-3376","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Effect of atropine 0.01% on progression of myopia"],"prefix":"10.4103","volume":"70","author":[{"given":"Snigdha","family":"Sen","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Sarojini Naidu Medical College, Agra, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Yadav","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Sarojini Naidu Medical College, Agra, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Sarojini Naidu Medical College, Agra, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadhna","family":"Verma","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, L.L.R.M. Medical College, Meerut, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Sarojini Naidu Medical College, Agra, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,8,26]]},"reference":[{"key":"B1-20240828","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1016\/S2214-109X(13)70113-X","article-title":"Causes of vision loss worldwide, 1990-2010:A systematic analysis","volume":"1","author":"Bourne","year":"2013","journal-title":"Lancet Glob Health"},{"key":"B2-20240828","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"key":"B3-20240828","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1167\/iovs.05-1081","article-title":"A cohort study of incident myopia in Singaporean children","volume":"47","author":"Saw","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B4-20240828","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3109\/02713688709034870","article-title":"Visual deprivation causesmyopia in chicks with optic nerve section","volume":"6","author":"Troilo","year":"1987","journal-title":"Curr Eye Res"},{"key":"B5-20240828","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ophtha.2012.11.009","article-title":"Outdoor activity during class recess reduces myopia onset and progression in school children","volume":"120","author":"Wu","year":"2013","journal-title":"Ophthalmology"},{"key":"B6-20240828","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/archopht.120.5.620","article-title":"Near work activity, night \u2013lights, and myopia in the Singapore \u2013China study","volume":"120","author":"Saw","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"B7-20240828","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1167\/iovs.07-1123","article-title":"The role of educational attainment in refraction;The genes in myopia (GEM) twin study","volume":"49","author":"Dirani","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B8-20240828","first-page":"1","article-title":"How genetic is school myopia?Prog Retin Eye Res","volume":"24","author":"Morgan","year":"2005"},{"key":"B9-20240828","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00006324-198707000-00002","article-title":"Houston Myopia Control Study:A randomized clinical trial Part II. Final report by the patient care team","volume":"64","author":"Grosvenor","year":"1987","journal-title":"Am J Optom Physiol Opt"},{"key":"B10-20240828","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF00160772","article-title":"Myopia progression in young school children and intraocular pressure","volume":"82","author":"Jensen","year":"1992","journal-title":"Doc Ophthalmol"},{"key":"B11-20240828","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.preteyeres.2012.06.004","article-title":"The complex interactions of retinal, optical and environmental factors in myopiaaetiology","volume":"31","author":"Filtcroft","year":"2012","journal-title":"Prog Retin Eyes"},{"key":"B12-20240828","doi-asserted-by":"crossref","first-page":"27","DOI":"10.47102\/https:\/\/doi.org\/10.47102\/annals-acadmedsg.V33N1p27","article-title":"Prevalence of myopia in Taiwanese school children:1983 to 2000","volume":"33","author":"Lin","year":"2004","journal-title":"Ann Acad Med Singapore"},{"key":"B13-20240828","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1167\/iovs.12-9943","article-title":"Muscarinic antagonist control of myopia:Evidence for M4 and M1 receptor \u2013based pathways in the inhibition of experimentally-induced axial myopia in the tree shrew","volume":"53","author":"Arumugam","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B14-20240828","first-page":"1434","article-title":"Muscarinic receptor subtypes in human iris-ciliary body measured by immunoprecipitation","volume":"38","author":"Gil","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B15-20240828","first-page":"2633","article-title":"Characterization of muscarinic receptors in human lens cells by pharmacologic and molecular techniques","volume":"41","author":"Collison","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B16-20240828","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0006-8993(88)91291-7","article-title":"Human retinal pigment epithelial cells possess muscarinic receptors coupled to calcium mobilization","volume":"446","author":"Friedman","year":"1988","journal-title":"Brain Res"},{"key":"B17-20240828","first-page":"1277","article-title":"Expression of muscarinic receptors in human and mouse sclera and their role in the regulation of sclera fibroblasts proliferation","volume":"15","author":"Barathi","year":"2009","journal-title":"Mol Vis"},{"key":"B18-20240828","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/02713680600770609","article-title":"The presence of M1 to M5 receptors in human sclera:Evidence of the sclera as a potential site of action for muscarinic receptor antagonists","volume":"31","author":"Qu","year":"2006","journal-title":"Curr Eye Res"},{"key":"B19-20240828","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1167\/iovs.14-15352","article-title":"Changing material properties of the tree shrew sclera during minus lens compensation and recovery","volume":"56","author":"Grytz","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B20-20240828","first-page":"205","article-title":"Atropine reduces experimental myopia and eyeenlargement via a non\u2013accommodative mechanism","volume":"34","author":"Mc Brien","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B21-20240828","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0014-4835(91)90027-C","article-title":"Muscarinic antagonis effects on experimental chick myopia","volume":"52","author":"Stone","year":"1991","journal-title":"Exp Eyes Res"},{"key":"B22-20240828","first-page":"1","article-title":"A longitudinal study of refraction and it's components during growth","volume":"309","author":"Sorsby","year":"1969","journal-title":"Spec Rep Ser Med Res Counc (GB)"},{"key":"B23-20240828","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s40123-019-0194-6","article-title":"A pilot study on the efficacy and safety of 0.01% atropine in German school children with progressive myopia","volume":"8","author":"Joachimsen","year":"2019","journal-title":"Ophthalmol Ther"},{"key":"B24-20240828","first-page":"281","article-title":"Reducing the progression of myopia with atropine:A long term cohort study of Olmsted Country students","volume":"15","author":"Kennedy","year":"2000","journal-title":"Binocul Vis Strabismus Q"},{"key":"B25-20240828","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","article-title":"Atropine for the treatment of childhood myopia:Safety and efficacy of 0.5%, 0.1% and 0.01% doses (Atropine for the Treatment of Myopia 2)","volume":"119","author":"Chia","year":"2012","journal-title":"Ophthalmology"},{"key":"B26-20240828","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low \u2013concentration Atropine for Myopia Progression (LAMP) Study:A randomized double blinded, placebo-controlled trial of 0.05%, 0.025%, 0.01% atropine eye drops in myopia control","volume":"126","author":"Yam","year":"2019","journal-title":"Ophthalmology"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_256_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:11:33Z","timestamp":1787757093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_256_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_256_22","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,26]]},"assertion":[{"value":"2022-03-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}